8-K

Company

Coherus Oncology, Inc.

Filed

August 2, 2023

Period of Report

August 2, 2023

Accession Number

0001558370-23-012903

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →